Aaron Henry Colby
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2017First federal award
$4.8MFederal grants as PI8 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
8 awards · $4.8M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jul 1, 2024 | NIH | SBIR Phase I Treating Second-Degree Burn Wound Infections with a Quorum Sensing Inhibitor | $300K | IONIC PHARMACEUTICALS, LLC |
| Aug 19, 2022 | NIH | SBIR Phase II Production of a dissolvable hydrogel-based wound dressing for second degree burns | $867K | IONIC PHARMACEUTICALS, LLC |
| Sep 15, 2021 | NIH | SBIR Phase II Production of a dissolvable hydrogel-based wound dressing for second degree burns | $830K | IONIC PHARMACEUTICALS, LLC |
| May 12, 2020 | NIH | SBIR Phase II Treating Peritoneal Malignancies with Paclitaxel-Loaded Expansile Nanoparticles | $1.0M | IONIC PHARMACEUTICALS, LLC |
| Jun 12, 2019 | NIH | SBIR Phase II Treating Peritoneal Malignancies with Paclitaxel-Loaded Expansile Nanoparticles | $983K | IONIC PHARMACEUTICALS, LLC |
| May 29, 2019 | NIH | SBIR Phase I Production of a dissolvable hydrogel-based wound dressing for second degree burns | $225K | IONIC PHARMACEUTICALS, LLC |
| May 17, 2018 | NIH | SBIR Phase I Fluorescent nanoparticles to improve resections of microscopic pancreatic tumors | $297K | IONIC PHARMACEUTICALS, LLC |
| Mar 15, 2017 | NIH | SBIR Phase I Improving delivery of paclitaxel to ovarian cancer via expansile nanoparticles | $283K | IONIC PHARMACEUTICALS, LLC |
Peer ranks
Federal funding#288
Awards as PI#190
Patents#273
Companies
- IONIC PHARMACEUTICALS, LLCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.